Teasing out the best molecular marker in the AKT/mTOR pathway in head and neck squamous cell cancer patients
Objectives/Hypothesis: No reliable molecular biomarker is currently available for clinical application in the management of head and neck cancer patients. The AKT/mTOR pathway is activated in 90% to 100% of head and neck squamous cell cancer (HNSCC) and could be promising biomarkers closely linked t...
Gespeichert in:
Veröffentlicht in: | The Laryngoscope 2010-06, Vol.120 (6), p.1159-1165 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!